{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["7(2)"],"submitter":["Yu H"],"pubmed_abstract":["<h4>What is already known about this topic?</h4>Human immunodeficiency virus (HIV) low-level viremia (LLV) during antiretroviral therapy (ART) occurs frequently in Dehong Dai and Jingpo Autonomous Prefecture, Yunnan Province.<h4>What is added by this report?</h4>Among people living with HIV who achieved virological success [viral load (VL) <1,000 copies/mL] after initiating ART in Dehong Prefecture, Southwest China, 17.6% experienced first-year LLV of 50-999 copies/mL First-year LLV emerged as an independent risk factor for subsequent viral non-suppression compared with participants maintaining first-year VL <50 copies/mL.<h4>What are the implications for public health practice?</h4>Enhanced monitoring and interventions for early LLV occurrence during the first year of ART are essential, i"],"journal":["China CDC weekly"],"pagination":["45-52"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11754852"],"repository":["biostudies-literature"],"pubmed_title":["Associations of First-Year Low-Level Viremia with Subsequent Viral Non-Suppression in People Living with HIV on Antiretroviral Therapy - Dehong Dai and Jingpo Autonomous Prefecture, Yunnan Province, China, 2008-2021."],"pmcid":["PMC11754852"],"pubmed_authors":["Feng Y","Cao D","Li P","Yu H","Shi Y","Yang Y","Jin C","Ye R","Cao Y","Xiao G","Duan S","Wei H","Sun J"],"additional_accession":[]},"is_claimable":false,"name":"Associations of First-Year Low-Level Viremia with Subsequent Viral Non-Suppression in People Living with HIV on Antiretroviral Therapy - Dehong Dai and Jingpo Autonomous Prefecture, Yunnan Province, China, 2008-2021.","description":"<h4>What is already known about this topic?</h4>Human immunodeficiency virus (HIV) low-level viremia (LLV) during antiretroviral therapy (ART) occurs frequently in Dehong Dai and Jingpo Autonomous Prefecture, Yunnan Province.<h4>What is added by this report?</h4>Among people living with HIV who achieved virological success [viral load (VL) <1,000 copies/mL] after initiating ART in Dehong Prefecture, Southwest China, 17.6% experienced first-year LLV of 50-999 copies/mL First-year LLV emerged as an independent risk factor for subsequent viral non-suppression compared with participants maintaining first-year VL <50 copies/mL.<h4>What are the implications for public health practice?</h4>Enhanced monitoring and interventions for early LLV occurrence during the first year of ART are essential, i","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jan","modification":"2025-04-05T10:18:21.07Z","creation":"2025-04-05T10:18:21.07Z"},"accession":"S-EPMC11754852","cross_references":{"pubmed":["39866288"],"doi":["10.46234/ccdcw2025.010"]}}